Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines.

Funston G, Van Melle M, Baun ML, Jensen H, Helsper C, Emery J, Crosbie EJ, Thompson M, Hamilton W, Walter FM.

BMC Cancer. 2019 Nov 1;19(1):1028. doi: 10.1186/s12885-019-6211-2.

2.

Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic review.

Zhou Y, van Melle M, Singh H, Hamilton W, Lyratzopoulos G, Walter FM.

BMJ Open. 2019 Oct 3;9(10):e029143. doi: 10.1136/bmjopen-2019-029143.

3.

Patient-Centered Outcomes From Multiparametric MRI and MRI-Guided Biopsy for Prostate Cancer: A Systematic Review.

Merriel SWD, Hardy V, Thompson M, Walter FM, Hamilton W.

J Am Coll Radiol. 2019 Sep 18. pii: S1546-1440(19)31032-4. doi: 10.1016/j.jacr.2019.08.031. [Epub ahead of print]

4.

Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.

Walter FM, Moodley JR.

Cancer Epidemiol. 2019 Sep 12:101597. doi: 10.1016/j.canep.2019.101597. [Epub ahead of print] No abstract available.

PMID:
31522952
5.

Dermoscopy for melanoma detection and triage in primary care: a systematic review.

Jones OT, Jurascheck LC, van Melle MA, Hickman S, Burrows NP, Hall PN, Emery J, Walter FM.

BMJ Open. 2019 Aug 20;9(8):e027529. doi: 10.1136/bmjopen-2018-027529.

6.

Development and validation of the African Women Awareness of CANcer (AWACAN) tool for breast and cervical cancer.

Moodley J, Scott SE, Mwaka AD, Constant D, Githaiga JN, Stewart TS, Payne A, Cairncross L, Somdyala NIM, Walter FM.

PLoS One. 2019 Aug 6;14(8):e0220545. doi: 10.1371/journal.pone.0220545. eCollection 2019.

7.

Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms.

Renzi C, Kaushal A, Emery J, Hamilton W, Neal RD, Rachet B, Rubin G, Singh H, Walter FM, de Wit NJ, Lyratzopoulos G.

Nat Rev Clin Oncol. 2019 Jul 26. doi: 10.1038/s41571-019-0249-6. [Epub ahead of print] Review.

PMID:
31350467
8.

Influence of doctor-patient conversations on behaviours of patients presenting to primary care with new or persistent symptoms: a video observation study.

Amelung D, Whitaker KL, Lennard D, Ogden M, Sheringham J, Zhou Y, Walter FM, Singh H, Vincent C, Black G.

BMJ Qual Saf. 2019 Jul 20. pii: bmjqs-2019-009485. doi: 10.1136/bmjqs-2019-009485. [Epub ahead of print]

9.

Risk Prediction Models for Colorectal Cancer Incorporating Common Genetic Variants: A Systematic Review.

McGeoch L, Saunders CL, Griffin SJ, Emery JD, Walter FM, Thompson DJ, Antoniou AC, Usher-Smith JA.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1580-1593. doi: 10.1158/1055-9965.EPI-19-0059. Epub 2019 Jul 10. Review.

PMID:
31292139
10.

Evaluating diagnostic strategies for early detection of cancer: the CanTest framework.

Walter FM, Thompson MJ, Wellwood I, Abel GA, Hamilton W, Johnson M, Lyratzopoulos G, Messenger MP, Neal RD, Rubin G, Singh H, Spencer A, Sutton S, Vedsted P, Emery JD.

BMC Cancer. 2019 Jun 14;19(1):586. doi: 10.1186/s12885-019-5746-6.

11.

Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma.

Murchie P, Masthoff J, Walter FM, Rahman K, Allan JL, Burrows N, Proby C, Lee AJ, Johnston M, Durrani A, Depasquale I, Brant B, Neilson A, Meredith F, Treweek S, Hall S, McDonald A.

Trials. 2019 Jun 3;20(1):318. doi: 10.1186/s13063-019-3453-x.

12.

Improving the Timely Detection of Bladder and Kidney Cancer in Primary Care.

Zhou Y, Funston G, Lyratzopoulos G, Walter FM.

Adv Ther. 2019 Jul;36(7):1778-1785. doi: 10.1007/s12325-019-00966-x. Epub 2019 May 17.

13.

Understanding implementation and usefulness of electronic clinical decision support (eCDS) for melanoma in English primary care: a qualitative investigation.

Pannebakker MM, Mills K, Johnson M, Emery JD, Walter FM.

BJGP Open. 2019 Mar 20;3(1):bjgpopen18X101635. doi: 10.3399/bjgpopen18X101635. eCollection 2019 Apr.

14.

Dermoscopy use in UK primary care: a survey of GPs with a special interest in dermatology.

Jones OT, Jurascheck LC, Utukuri M, Pannebakker MM, Emery J, Walter FM.

J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1706-1712. doi: 10.1111/jdv.15614. Epub 2019 May 17.

15.

Defining unmet clinical need across the pathway of brain tumor care: a patient and carer perspective.

Sage W, Fernández-Méndez R, Crofton A, Gifford MJ, Bannykh A, Chrysaphinis C, Tingley E, Bulbeck H, Brahmbhatt M, Pickard JD, Walter FM, Brodbelt A, Price SJ, Joannides AJ.

Cancer Manag Res. 2019 Mar 19;11:2189-2202. doi: 10.2147/CMAR.S175886. eCollection 2019.

16.

'It was nothing that you would think was anything': Qualitative analysis of appraisal and help seeking preceding brain cancer diagnosis.

Scott SE, Penfold C, Saji S, Curtis S, Watts C, Hamilton W, Joannides AJ, Walter FM.

PLoS One. 2019 Mar 22;14(3):e0213599. doi: 10.1371/journal.pone.0213599. eCollection 2019.

17.

Missed opportunities for diagnosing brain tumours in primary care: a qualitative study of patient experiences.

Walter FM, Penfold C, Joannides A, Saji S, Johnson M, Watts C, Brodbelt A, Jenkinson MD, Price SJ, Hamilton W, Scott SE.

Br J Gen Pract. 2019 Apr;69(681):e224-e235. doi: 10.3399/bjgp19X701861. Epub 2019 Mar 11.

18.

Do cognitive heuristics underpin symptom appraisal for symptoms of cancer?: A secondary qualitative analysis across seven cancers.

Kummer S, Walter FM, Chilcot J, Emery J, Sutton S, Scott SE.

Psychooncology. 2019 May;28(5):1041-1047. doi: 10.1002/pon.5049. Epub 2019 Mar 18.

PMID:
30828881
19.

Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.

Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, de Villiers CB, Izquierdo A, Simard J, Schmidt MK, Walter FM, Chatterjee N, Garcia-Closas M, Tischkowitz M, Pharoah P, Easton DF, Antoniou AC.

Genet Med. 2019 Jun;21(6):1462. doi: 10.1038/s41436-019-0459-4.

PMID:
30787466
20.

Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study.

Barclay ME, Lyratzopoulos G, Walter FM, Jefferies S, Peake MD, Rintoul RC.

Thorax. 2019 May;74(5):466-472. doi: 10.1136/thoraxjnl-2018-212456. Epub 2019 Feb 18.

21.

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.

Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, Babb de Villiers C, Izquierdo A, Simard J, Schmidt MK, Walter FM, Chatterjee N, Garcia-Closas M, Tischkowitz M, Pharoah P, Easton DF, Antoniou AC.

Genet Med. 2019 Aug;21(8):1708-1718. doi: 10.1038/s41436-018-0406-9. Epub 2019 Jan 15. Erratum in: Genet Med. 2019 Feb 21;:.

22.

The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer.

Emery JD, Murray SR, Walter FM, Martin A, Goodall S, Mazza D, Habgood E, Kutzer Y, Barnes DJ, Murchie P.

Thorax. 2019 Apr;74(4):362-370. doi: 10.1136/thoraxjnl-2018-212506. Epub 2019 Jan 10.

23.

Associations between general practice characteristics with use of urgent referrals for suspected cancer and endoscopies: a cross-sectional ecological study.

Mendonca SC, Abel GA, Gildea C, McPhail S, Peake MD, Rubin G, Singh H, Hamilton W, Walter FM, Roland MO, Lyratzopoulos G.

Fam Pract. 2019 Oct 8;36(5):573-580. doi: 10.1093/fampra/cmy118.

24.

Teledermatology for diagnosing skin cancer in adults.

Chuchu N, Dinnes J, Takwoingi Y, Matin RN, Bayliss SE, Davenport C, Moreau JF, Bassett O, Godfrey K, O'Sullivan C, Walter FM, Motley R, Deeks JJ, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group.

Cochrane Database Syst Rev. 2018 Dec 4;12:CD013193. doi: 10.1002/14651858.CD013193.

PMID:
30521686
25.

Smartphone applications for triaging adults with skin lesions that are suspicious for melanoma.

Chuchu N, Takwoingi Y, Dinnes J, Matin RN, Bassett O, Moreau JF, Bayliss SE, Davenport C, Godfrey K, O'Connell S, Jain A, Walter FM, Deeks JJ, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group.

Cochrane Database Syst Rev. 2018 Dec 4;12:CD013192. doi: 10.1002/14651858.CD013192.

PMID:
30521685
26.

Visual inspection for diagnosing cutaneous melanoma in adults.

Dinnes J, Deeks JJ, Grainge MJ, Chuchu N, Ferrante di Ruffano L, Matin RN, Thomson DR, Wong KY, Aldridge RB, Abbott R, Fawzy M, Bayliss SE, Takwoingi Y, Davenport C, Godfrey K, Walter FM, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group.

Cochrane Database Syst Rev. 2018 Dec 4;12:CD013194. doi: 10.1002/14651858.CD013194.

PMID:
30521684
27.

Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults.

Dinnes J, Deeks JJ, Chuchu N, Ferrante di Ruffano L, Matin RN, Thomson DR, Wong KY, Aldridge RB, Abbott R, Fawzy M, Bayliss SE, Grainge MJ, Takwoingi Y, Davenport C, Godfrey K, Walter FM, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group.

Cochrane Database Syst Rev. 2018 Dec 4;12:CD011902. doi: 10.1002/14651858.CD011902.pub2.

PMID:
30521682
28.

Towards timely diagnosis of symptomatic breast and cervical cancer in South Africa.

Moodley J, Walter FM, Scott SE, Mwaka AM.

S Afr Med J. 2018 Oct 2;108(10):803-804. doi: 10.7196/SAMJ.2018.v108i10.13478. No abstract available.

29.

The influence of health literacy on the timely diagnosis of symptomatic cancer: A systematic review.

Humphrys E, Burt J, Rubin G, Emery JD, Walter FM.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12920. doi: 10.1111/ecc.12920. Epub 2018 Oct 16.

30.

The Aarhus statement on cancer diagnostic research: turning recommendations into new survey instruments.

Coxon D, Campbell C, Walter FM, Scott SE, Neal RD, Vedsted P, Emery J, Rubin G, Hamilton W, Weller D.

BMC Health Serv Res. 2018 Sep 3;18(1):677. doi: 10.1186/s12913-018-3476-0.

31.

Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux.

Offman J, Muldrew B, O'Donovan M, Debiram-Beecham I, Pesola F, Kaimi I, Smith SG, Wilson A, Khan Z, Lao-Sirieix P, Aigret B, Walter FM, Rubin G, Morris S, Jackson C, Sasieni P, Fitzgerald RC; BEST3 Trial team.

BMC Cancer. 2018 Aug 3;18(1):784. doi: 10.1186/s12885-018-4664-3.

32.

The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.

Walker JG, Macrae F, Winship I, Oberoi J, Saya S, Milton S, Bickerstaffe A, Dowty JG, De Abreu Lourenço R, Clark M, Galloway L, Fishman G, Walter FM, Flander L, Chondros P, Ait Ouakrim D, Pirotta M, Trevena L, Jenkins MA, Emery JD.

Trials. 2018 Jul 25;19(1):397. doi: 10.1186/s13063-018-2764-7.

33.
34.

Delivery and impact of the NHS Health Check in the first 8 years: a systematic review.

Martin A, Saunders CL, Harte E, Griffin SJ, MacLure C, Mant J, Meads C, Walter FM, Usher-Smith JA.

Br J Gen Pract. 2018 Jul;68(672):e449-e459. doi: 10.3399/bjgp18X697649. Epub 2018 Jun 18.

35.

Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling: An Application to Rates of Disease Progression in Undiagnosed and Untreated Melanoma.

Wilson ECF, Usher-Smith JA, Emery J, Corrie PG, Walter FM.

Value Health. 2018 Jun;21(6):669-676. doi: 10.1016/j.jval.2017.10.009. Epub 2017 Dec 8.

36.

A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom.

Wilson ECF, Usher-Smith JA, Emery J, Corrie P, Walter FM.

Value Health. 2018 Jun;21(6):658-668. doi: 10.1016/j.jval.2017.11.009. Epub 2018 Apr 11.

37.

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence.

Brett J, Boulton M, Fenlon D, Hulbert-Williams NJ, Walter FM, Donnelly P, Lavery BA, Morgan A, Morris C, Watson EK.

Patient Prefer Adherence. 2018 Feb 16;12:291-300. doi: 10.2147/PPA.S145784. eCollection 2018.

38.

The Improving Rural Cancer Outcomes Trial: a cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia.

Emery JD, Gray V, Walter FM, Cheetham S, Croager EJ, Slevin T, Saunders C, Threlfall T, Auret K, Nowak AK, Geelhoed E, Bulsara M, Holman CDJ.

Br J Cancer. 2018 Mar 20;118(6):e8. doi: 10.1038/bjc.2017.457. Epub 2018 Feb 15.

39.

Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.

Stewart TS, Moodley J, Walter FM.

Cancer Epidemiol. 2018 Apr;53:81-92. doi: 10.1016/j.canep.2018.01.014. Epub 2018 Feb 4.

PMID:
29414636
40.

External validation of risk prediction models for incident colorectal cancer using UK Biobank.

Usher-Smith JA, Harshfield A, Saunders CL, Sharp SJ, Emery J, Walter FM, Muir K, Griffin SJ.

Br J Cancer. 2018 Mar 6;118(5):750-759. doi: 10.1038/bjc.2017.463. Epub 2018 Jan 30.

41.

Psychometric properties of the Beliefs about Medicine Questionnaire-adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer.

Brett J, Hulbert-Williams NJ, Fenlon D, Boulton M, Walter FM, Donnelly P, Lavery B, Morgan A, Morris C, Horne R, Watson E.

Health Psychol Open. 2017 Nov 17;4(2):2055102917740469. doi: 10.1177/2055102917740469. eCollection 2017 Jul-Dec.

42.

Supporting prostate cancer survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational intervention (PROSPECTIV).

Watson EK, Shinkins B, Matheson L, Burns RM, Frith E, Neal D, Hamdy F, Walter FM, Weller D, Wilkinson C, Faithfull S, Sooriakumaran P, Kastner C, Campbell C, Neal RD, Butcher H, Matthews M, Perera R, Wolstenholme J, Rose PW.

Eur J Oncol Nurs. 2018 Feb;32:73-81. doi: 10.1016/j.ejon.2017.12.002. Epub 2017 Dec 29.

PMID:
29353635
43.

Associations between diagnostic activity and measures of patient experience in primary care: a cross-sectional ecological study of English general practices.

Lyratzopoulos G, Mendonca SC, Gildea C, McPhail S, Peake MD, Rubin G, Singh H, Hamilton W, Walter FM, Roland M, Abel GA.

Br J Gen Pract. 2018 Jan;68(666):e9-e17. doi: 10.3399/bjgp17X694097. Epub 2017 Dec 18.

44.

Symptom Signatures and Diagnostic Timeliness in Cancer Patients: A Review of Current Evidence.

Koo MM, Hamilton W, Walter FM, Rubin GP, Lyratzopoulos G.

Neoplasia. 2018 Feb;20(2):165-174. doi: 10.1016/j.neo.2017.11.005. Epub 2017 Dec 16. Review.

45.

The researchers' role in knowledge translation: a realist evaluation of the development and implementation of diagnostic pathways for cancer in two United Kingdom localities.

Banks J, Wye L, Hall N, Rooney J, Walter FM, Hamilton W, Gjini A, Rubin G.

Health Res Policy Syst. 2017 Dec 13;15(1):103. doi: 10.1186/s12961-017-0267-8.

46.

Possible missed opportunities for diagnosing colorectal cancer in Dutch primary care: a multimethods approach.

Brandenbarg D, Groenhof F, Siewers IM, van der Voort A, Walter FM, Berendsen AJ.

Br J Gen Pract. 2018 Jan;68(666):e54-e62. doi: 10.3399/bjgp17X693905. Epub 2017 Dec 4.

47.

Reasons why people do not attend NHS Health Checks: a systematic review and qualitative synthesis.

Harte E, MacLure C, Martin A, Saunders CL, Meads C, Walter FM, Griffin SJ, Mant J, Usher-Smith JA.

Br J Gen Pract. 2018 Jan;68(666):e28-e35. doi: 10.3399/bjgp17X693929. Epub 2017 Dec 4.

48.

Protocol for the melatools skin self-monitoring trial: a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma.

Mills K, Emery J, Lantaff R, Radford M, Pannebakker M, Hall P, Burrows N, Williams K, Saunders CL, Murchie P, Walter FM.

BMJ Open. 2017 Nov 28;7(11):e017934. doi: 10.1136/bmjopen-2017-017934.

49.

Variation in 'fast-track' referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites.

Zhou Y, Mendonca SC, Abel GA, Hamilton W, Walter FM, Johnson S, Shelton J, Elliss-Brookes L, McPhail S, Lyratzopoulos G.

Br J Cancer. 2018 Jan;118(1):24-31. doi: 10.1038/bjc.2017.381. Epub 2017 Nov 28.

50.

Reducing barriers to consulting a General Practitioner in patients at increased risk of lung cancer: a qualitative evaluation of the CHEST Australia intervention.

Murray SR, Kutzer Y, Habgood E, Murchie P, Walter FM, Mazza D, Shahid S, Emery JD.

Fam Pract. 2017 Nov 16;34(6):740-746. doi: 10.1093/fampra/cmx057.

Supplemental Content

Loading ...
Support Center